Kanaan Atef, Cour Isabel, Alvarez-Lafuente Roberto, Benedicto Mar, Culebras Esther, Prats Dolores, Fernández Cristina, Picazo Juan J
Department of Microbiology, Hospital Clínico San Carlos, C/ Profesor Martín Lagos s/n, 28040 Madrid, Spain.
Int J Antimicrob Agents. 2004 Nov;24(5):455-62. doi: 10.1016/j.ijantimicag.2004.06.012.
Immunocompromised renal transplant recipients are susceptible to severe cytomegalovirus (CMV) infection that makes its detection important in clinical practice. A total of 536 blood and 536 serum samples from 67 renal transplant recipients who had previously been diagnosed with terminal renal insufficiency were studied for CMV infection. In all samples, serology, shell vial culture, antigenaemia and nested polymerase chain reaction (PCR) in blood and serum were tested, and a real-time quantitative PCR was run on 90 specimens. Sixty-seven blood donors were used as controls. The results show that the quantitative real-time PCR assay could be of great interest for predicting CMV disease, and to monitor the onset of pre-emptive therapy.
免疫功能低下的肾移植受者易发生严重的巨细胞病毒(CMV)感染,因此在临床实践中检测CMV感染非常重要。对67例先前被诊断为终末期肾功能不全的肾移植受者的536份血液样本和536份血清样本进行了CMV感染研究。对所有样本进行了血清学、空斑试验培养、抗原血症检测以及血液和血清中的巢式聚合酶链反应(PCR),并对90份标本进行了实时定量PCR检测。67名献血者用作对照。结果表明,实时定量PCR检测对于预测CMV疾病以及监测抢先治疗的开始可能具有重要意义。